HIV SEROPREVALENCE (% 0F POPULATION) Capital/Major City Country Low Risk High Risk CARIBBEAN Antigua and Barbuda 1.7 Bahamas 3.6 18.4 Barbados 1.2 4.7 British Virgin Islands 2.8 * Cayman Islands .0 Cuba .0 .0 Dominican Republic 1.3 5.0 Grenada .0 2.4 * Haiti 15.7 41.9 Jamaica .3 14.6 * Martinique .5 38.9 * Montserrat .0 St. Kitts and Nevis 2.0 St. Lucia .0 1.2 St. Vincent and Grens. .2 1.4 Trinidad and Tobago .2 14.7 CENTRAL AMERICA Costa Rica 1.1 4.3 El Salvador .3 * 2.2 Guatemala .0 .7 Honduras .2 19.8 Nicaragua .0 1.6 * Panama .0 SOUTH AMERICA Argentina .3 6.3 Bolivia .0 .0 Brazil .8 24.0 Chile .0 1.0 Colombia .1 14.6 Ecuador .0 * .5 Guyana 6.9 25.0 * Paraguay .0 .1 Peru .1 .3 Suriname .8 2.6 Uruguay .1 5.6 Venezuela .1 6.1 * Mexico .1 * 2.2 Source: U.S. Bureau of the Census: 1994 HIV/AIDS Surveillance Data Base Definition: HIV Seroprevalence means tested positive for HIV I antibodies * Data are best available but are not necessarily reliable due to small sample size (<100)